自用皮下注射系统－设备、市场、参与者及预测

Self-Administered On-Body Subcutaneous Infusion Systems - Devices, Markets, Players and Forecasts

出版日期: 2025年11月18日 | 出版商:

Greystone Research Associates | 英文 72 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

自用皮下注射技术是对推动医疗保健产业这一新兴领域的技术、产品和参与者的全面评估和分析。本研究旨在为製药决策者、药物传输技术开发人员、医疗器材设计师、医疗保健行销人员和供应链利益相关者提供关于护理点自註射和自用皮下注射设备的经济性、技术性、疾病领域和商业机会的详细了解。医疗保健高管、医疗保健管理人员和投资者也将从中获得宝贵的见解。

推动皮下注射成长的融合因子

随着预灌封设备在剂量和整体行业收入方面不断取代小瓶，製药和生物技术专案经理正越来越多地将注射器和自註射设备技术整合到他们的开发计划中。这促使了多功能开发团队的兴起，以及对加速产品可行性测试的日益依赖。

本研究的洞见：

目前市面上或正在研发的门诊皮下输注系统有哪些？供应商有哪些？具体的设备规格是什么？
家用皮下输注系统面向哪些治疗市场？
门诊皮下输注系统的基本设计要素、材料选择挑战、技术挑战、市场开发挑战是什么？
推动便携式皮下输注系统需求的关键因素是什么？
皮下输注系统的潜在市场规模有多大？
皮下输注系统对药物输送市场的预期影响为何？
该领域的主要参与者有哪些？他们的战略是什么？他们的联盟伙伴有哪些？

研究方法

本研究方法是基于对主要市场参与者、技术开发商、经销商、产业专家和市场影响者（包括监管机构、产业协会和材料标准组织）的深入访谈，以进行一手研究。

一手资料会根据二手资料进行评估和标准化，这些二手资料包括行业期刊文章、技术文献、行业出版物、公司资料表、公开资讯以及来自政府机构和行业协会的统计资料。

市场需求和未来市场趋势的预测和展望采用标准建模和统计技术得出。

综合评估
目录
摘要整理
注射/输注市场区隔趋势
药物研发趋势
给药装置的演变
患者自我给药趋势
使能技术
冷冻干燥药物/復溶
皮下输注系统 - 设计因素
容量和黏度
初级包装
输注法
装置电子元件
皮下输注装置 - 市场区隔
门诊输注成本与物流负担
生物製剂
大容量药物
持续时间相关因素药物
皮下输注系统设备分析
enFuse（Enable Injections）
Libertas（Becton Dickinson）
Evolve（Becton Dickinson）
SensePatch（Sensile Medical/Gerresheimer）
SmartDose（West Pharmaceuticals）
SmartDose Preload（West Pharmaceuticals）
非品牌器材（Sorrel Medical）
非品牌设备（Subject）
YpsoDose（Ypsomed）
E3D 贴片帮浦（Elcam）
Pods（Stevanato）
市场因素
自我给药与病人依从性
监管指南和产品审批
卫生经济学
药物差异化
市场参与者概况

简介目录

Self-administered On-Body Subcutaneous Infusion is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for devices that can self-administer injectable/infusible drugs subcutaneously at the point-of-care. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Converging Factors Driving the Growth of Subcutaneous Infusion

As prefilled devices continue to replace vials in terms of doses as well as total sector revenue, pharmaceutical and biotech program managers are increasingly integrating syringe and self-injection device technology into their development plans. The result has been a migration toward multi-functional development teams and an increasing reliance on accelerated product feasibility testing.

What You Will Learn:

What ambulatory subcutaneous infusion systems are currently marketed or in development, who are the suppliers, and what are the device specifics?
What are the therapeutic markets being targeted by ambulatory subcutaneous infusion systems?
What are the essential design factors, material selection issues, technologies and market development issues for ambulatory subcutaneous infusion systems?
What are the major factors that will drive ambulatory subcutaneous infusion systems demand?
What is the addressable market for subcutaneous infusion systems?
What is the expected impact of subcutaneous infusion systems on drug delivery markets?
Who are the significant players in this segment? What are their strategies? Who are their alliance partners?

Methodology

Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.

Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.